About
Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
Apr 15 2026
Reviva Announces Letter to Shareholders
Mar 30 2026
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
Mar 23 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
Jan 8 2026
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
Financials
Revenue
$0
Market Cap
$9.22 M
EPS
-5.48
Translate